Alnylam Pharmaceuticals, Inc. (ALNY)

Biotechnology

ALNY · NASDAQ NMS - GLOBAL MARKET · USD

New to investing? How to read this page →

$298.77

−4.43%

Watch Compare

Price · 1 year

Watch + Add to portfolio

Loading live analysis…

Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS

$2.33

ROE

90.4%

Gross margin

80.8%

Debt/Equity

2.76x

Revenue growth

96.4%

Alnylam Pharmaceuticals, Inc. — company intelligence

Earnings surprises

Q1 2026$1.51 vs $0.96 est+56.5%

Q4 2025$0.82 vs $1.15 est-28.5%

Q3 2025$2.11 vs $0.76 est+177.2%

Q2 2025$-0.51 vs $-0.73 est+30.6%

Insider activity · 90 days

19 buys5 sellsnet +20,099 shares

PYOTT DAVID E ISell 495 · Jun 1, 2026

PYOTT DAVID E ISell 921 · Jun 1, 2026

PYOTT DAVID E ISell 1,175 · Jun 1, 2026

Recent SEC filings

4 — Insider transaction reportJun 3, 2026

8-K — Material event reportMay 27, 2026

Latest news

Can Alnylam's Drug Pipeline Fuel Its Long-Term Revenue Growth? — Yahoo · 4d ago

Alnylam Pharmaceuticals (NASDAQ:ALNY): An Affordable Growth Stock with Explosive Momentum and a Reasonable Price — ChartMill · 1w ago

What Offers Alnylam Pharmaceuticals (ALNY) Sustained Long-Term Growth? — Yahoo · 1w ago

Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right. — Yahoo · 1w ago

Komodo Expands Strategic Partnership with Alnylam Pharmaceuticals, Inc. (ALNY) — Yahoo · 1w ago

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen Stocks Learn Intrinsic Value Trading Signals Compare Stocks

Explore more

More in Biotechnology →More in Biotechnology →Stocks in US →Stocks on NASDAQ NMS - GLOBAL MARKET →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

AbbVie IncABBV Amgen Inc.AMGN Gilead Sciences, Inc.GILD Vertex Pharmaceuticals IncorporVRTX Regeneron Pharmaceuticals, Inc.REGN Revolution Medicines IncRVMD

About Alnylam Pharmaceuticals, Inc.

Weekly undervalued picks (like ALNY)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.